Efficacy and Safety of Daratumumab in a Frail Real-Life Relapsed or Refractory Systemic Light-Chain Amyloidosis Population (AL): Report on 15 Cases from the North of FranceZoé Van de Wyngaert, Eileen M. Boyle, Thierry Façon et al.|Blood|2018Cited by 6
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies: Insights from a large-scale NGS-based screening studyLeïla Ben Dhia, Nicolas Duployez, Pascal Huchette et al.|Blood|2025Cited by 0